查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197857

OPEP 设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-28)

Oscillating Positive Expiratory Pressure (OPEP) Devices Market - Growth, Trends, and Forecasts (2023-28)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，欧佩普（OPEP）设备市场预测的年復合增长率提高了5.3%。

因为疫情的爆发，多模式慢性肺病患者的市场受到了影响。 2021 年 10 月，ERJ 发表了一项描述性单项研究，有呼吸系统疾病史的患者比例、严重的 COVID-19 样风和呼吸系统疾病史患者的死亡率增加。 同样，国家生物技术信息中心 (NCBI) 于 2021 年 7 月进行的一项描述性单项研究在 COVID-19 慢性呼吸道疾病患者中很常见。 大流行早期呼吸道疾病病例增加了推进和振动常压呼吸设备的需求，用于清除呼吸道疾病患者的肺部粘液。

起初，对OPEP设备的需求激增，但疫情结束后，需求急剧下降。

然而，肺炎和哮喘等呼吸系统疾病患者数量增加，OPEP设备市场在预测期内持续增长。

例如，NCBI 在 2021 年 6 月的 Expressive Single Study，慢性呼吸道疾病对国家、地区和全球疾病有严重影响。 根据该研究报告，发病率和死亡率的发生率较低，发病率中等偏高。 同样，Nezu Lung India 在 2021 年 12 月发布的一份初步报告中指出，到 2021 年，印度男性和女性的慢性阻塞性肺病 (COPD) 患病率将达到 11.4%。 同样，2021年版的祢豆子的ERS，2020年约有36,580,965名COPD患者，Mordor Intelligence分析预测，2050年约有49,453,852名COPD患者。

COPD发病率高的理髮创新设备及科研人员晋升。 例如，NCBI 于 2021 年 1 月发表了第二项研究，全球 COPD 病例呈上升趋势，并引入了气管内窥镜等新的先进设备和新的手术程序。 因此，预测的呼吸系统疾病高发病率的积极进展将推动对OPEP设备的需求，市场增长将随之而来。

此外，OPEP设备相关技术进步，驱动市场持续增长。 例如，2021 年 10 月 BMC Pulmonary Medicine 的一项单学期研究表明，可重复使用的 OPEP 设备现在需要定期清洁和消毒，从而防止隐藏的病原微生物。 然而，遵守呼吸设备清洁措施通常是关键。 出于这个原因，在初级 OPEP 设施原型 UL-OPEP 开发之后，出现了低病原体感染的趋势。 种子技术进步并创造了新的市场机会，吸引了许多新进入者，并促进了增长。

另一方面，由于熟练专业人员的短期短缺，预测期内的市场增长。

OPEP设备市场趋势

预测期内 COPD 区域的当前最大增长

哮喘是影响全世界儿童的最常见的慢性呼吸道疾病。 哮喘是一种影响肺部呼吸道的慢性（长期）疾病。 气道是输送空气的肺道。 哮喘患者合併气胸和气道收缩。 防止爬行呼出空气分隔的呼吸道。 COPD 是一组肺部疾病，会导致呼吸困难并随时间恶化。 慢性阻塞性肺疾病在全球范围内的高发病率是推动该地区增长的主要因素之一。

例如，ERJ Open Research 2022年8月出版第一版，ISAAC问卷调查，全球11-16岁儿童坐骨性支气管哮喘发病率：13.1%。 我在这。 据报导，全球婴儿哮喘患病率为10.2%。 同样，Nezuo ScienceDirect，第一期出版于 2022 年 1 月，2021 年 SAT-Arabo 的哮喘发病率为 14.2%。

此外，日本疾病预防控制中心2022年7月发布的一份综合报告显示，2021年中国慢性阻塞性肺疾病超标率为5.6%。 5-29 岁人群 COPD 患病率中位数为 0.1%-0.9%，到 2021 年 30-30 岁人群将增加 1.6%-28.3%。 对OPEP设备的需求不断增加，细分市场增长也被看好。

北美当期最长增速

在当前调查期间，以 Keiji Kitami 为首的 OPEP 设备市场。 该物种的增长是由于呼吸系统疾病病例增加和研究活动增加等因素造成的。 例如，在 2021 年 6 月的加拿大哮喘协会初步报告中，超过 850,000 名 14 岁以下儿童患有哮喘病，这是 14 岁以下儿童中最常见的慢性疾病，也是住院治疗的主要原因。 同样，Nezuko CMAJ Group 于 2021 年 5 月发表，哮喘是儿童最常见的慢性疾病，在加拿大的患病率为 15.0% 至 25.0%。

主要产品发布、市场参与者和製造商高度集中、主要参与者之间的采购合作以及美国呼吸系统疾病病例的增加是该国OPEP设备市场增长的驱动因素。 一项成就。 比如2022年8月发表的NCBI研究，在美国，每年的肺炎发病率为每10,000名成年人24.8例，而且每年的增长率还在上升。

OPEP设备市场竞争分析

全球 OPEP 设备市场竞争激烈。 Competitiveness Bureau 与市场上少数知名公司的综合分析，例如 AirPhysio、D-R Burton Healthcare、Medica Holdings, LLC、Monaghan Medical Corporation、PARI GmbH 等知名公司。 Cegla GmbH &Co.KG 和 Smiths Medical, Inc.

其他地方

  • Excel 的正式市场预测 (ME) 表
  • 三元分析支持

内容

第一章介绍

  • 研究度假村市场的定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 全球慢性呼吸道疾病增加
    • 牢不可破的技术进步
  • 市场因素
    • 缺乏熟练的专业人员
  • 特定于波浪的五力分析
    • 新人威胁
    • 买家/消费者关係能力
    • 商业议价能力
    • 替代威胁
    • 竞争公司之间的竞争

第五章市场细分（基础市场规模：亿元）

  • 安排产品类型
    • 面对面的 PEP 设备
    • 喉部 PEP 设备
    • 瓶型PEP装置
  • 舍入说明
    • 慢性阻塞性肺病
    • 脊膜炎
    • 囊性纤维化
    • 其他
  • 最终用途
    • 日本诊所
    • 专注于门诊手术
    • 其他
  • 安吉区
    • 北方美女
      • 美国
      • 金代
      • 木斋阁
    • 涠洲岛
      • 出国
      • 英国
      • 北谷 <李>
      • 西方毒牙
      • 其他西部地区
    • 阿泰吉区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚洲太极地区
    • 世界其他地区 (ROW)

第六章竞争局

  • 关于公司的信息
    • AirPhysio
    • Smiths Medical
    • D-R Burton Healthcare
    • Medica Holdings, LLC
    • Monaghan Medical Corporation
    • PARI GmbH
    • R. Cegla GmbH & Co. KG

第7章 市场机会今后动向

简介目录
Product Code: 69705

The oscillating positive expiratory pressure (OPEP) devices market is expected to register a CAGR of 5.3% over the forecast period.

The increased number of cases of chronic pulmonary diseases with the outbreak of the pandemic has impacted the market. According to a study published by the ERJ in October 2021, patients with prior influenza were at higher risk of developing severe COVID-19 and had a higher mortality rate than patients without a history of respiratory illness. Similarly, per a study published by the National Center for Biotechnology Information (NCBI) in July 2021, chronic respiratory diseases were common among patients with COVID-19. Increasing cases of respiratory diseases in the initial days of the pandemic propelled the demand for oscillating positive expiratory pressure devices as it is used to clear mucus from the lungs of individuals with respiratory illnesses.

Although there was a sharp rise in demand for OPEP devices initially, it has now reduced greatly now that the pandemic has ended.

However, the OPEP devices market is expected to maintain growth over the forecast period owing to growing cases of other respiratory diseases such as pneumonia and asthma.

For instance, according to a study published by the NCBI in June 2021, chronic respiratory diseases contribute significantly to the national, regional, and global burden of disease. The study also reported that morbidity and mortality from such conditions are estimated to be high in low- and middle-income countries. Similarly, as per the report published by Lung India in December 2021, the prevalence rate of chronic obstructive pulmonary disease (COPD) among males and females was 11.4% in India in 2021. Similarly, as per the ERS journal of 2021, it was estimated that around 36,580,965 Europeans suffered from COPD in 2020 and as per Mordor Intelligence analysis around 49,453,852 Europeans were expected to suffer from COPD in 2050.

Owing to such a high prevalence of COPD the researchers are also focusing on developing innovative and new devices for advanced treatment. For instance, as per another study published by the NCBI in January 2021, due to the increasing cases of COPD across the globe, the researchers were focusing on developing new advanced devices and novel surgical and bronchoscopic procedures. Therefore, such positive advancements and a high prevalence of respiratory diseases are anticipated to propel the demand for OPEP devices, thereby surging market growth.

Furthermore, the technological advancements related to OPEP devices are also pushing market growth. For instance, as per a study published by BMC Pulmonary Medicine in October 2021, currently, reusable OPEP devices are available that require regular cleaning and disinfection to prevent harboring of potentially pathogenic organisms. However, adherence to cleaning regimens for respiratory devices is often critical. Therefore, a prototype single-use OPEP device - "UL-OPEP" was developed to mitigate the risk of pathogen contamination. Such technological advancements and innovations may create opportunities for the market, which in turn may encourage many new players to enter the market and drive growth.

On the other hand, a lack of skilled professionals is likely to hinder the market growth over the forecast period.

Oscillating Positive Expiratory Pressure Devices Market Trends

COPD and Asthma Segment is Expected to Witness Largest Growth Over the Forecast Period

Asthma is the most common chronic respiratory disease affecting children globally. Asthma is a chronic (long-term) condition that affects the airways in the lungs. The airways are the tubes that carry air in and out of your lungs. The airways of asthma patients can sometimes become inflamed and narrow. This makes it difficult for air to flow out of the airways when exhaling. COPD is a group of lung diseases that make breathing difficult and worsen over time. The high prevalence of asthma and COPD across the globe is one of the major factors propelling the segment's growth.

For instance, per the journal published by the ERJ Open Research in August 2022, a study based on the ISAAC questionnaire reported a prevalence of bronchial asthma of 13.1% in children aged 11 to 16 years globally. It also reported that, globally, the prevalence of asthma in children was 10.2%. Similarly, as per a journal published by ScienceDirect in January 2022, the overall prevalence of asthma in Saudi Arabia was 14.2% in 2021.

Furthermore, per a report published by the CDC in July 2022, the overall prevalence rate of COPD in the United States in 2021 was more than 5.6%. The prevalence of COPD among individuals aged 5 to 29 years was found to range from 0.1% to 0.9%, increasing to 1.6% to 28.3% in the population aged 30 years in 2021. Such instances indicate that the demand for OPEP devices is anticipated to increase, propelling segment growth.

North America is Expected to Witness Largest Growth Over the Forecast Period

North America is expected to dominate the overall OPEP devices market over the forecast period. The growth is due to factors such as increasing cases of pediatric respiratory diseases and increasing research work. For instance, as per a report published by Asthma Canada in June 2021, more than 850,000 children under the age of 14 had asthma, thereby making it the most common chronic disease among children and the leading cause of both school absenteeism and hospitalization in Canada. Similarly, per a journal published by the CMAJ Group in May 2021, asthma is the most common chronic disease in children, with a prevalence of 15.0% to 25.0% in Canada.

Key product launches, high concentration of market players or manufacturer's presence, acquisition and partnerships among major players, and increasing cases of respiratory diseases in the United States are some of the factors driving the growth of the OPEP devices market in the country. For instance, as per an NCBI study published in August 2022, in the United States, the annual incidence of pneumonia is 24.8 cases per 10,000 adults, with higher rates as age increases.

Oscillating Positive Expiratory Pressure Devices Market Competitor Analysis

The global OPEP devices market is competitive and consists of very few major players. The competitive landscape includes an analysis of a few international as well as local companies which hold considerable market shares and are well-known, including AirPhysio, D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, and Smiths Medical, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Respiratory Diseases Across the Globe
    • 4.2.2 Growing Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product Type
    • 5.1.1 Face Mask PEP Devices
    • 5.1.2 Mouthpiece PEP Devices
    • 5.1.3 Bottle PEP Devices
  • 5.2 By Indication
    • 5.2.1 COPD and Asthma
    • 5.2.2 Bronchitis
    • 5.2.3 Cystic Fibrosis
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospital and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World (ROW)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AirPhysio
    • 6.1.2 Smiths Medical
    • 6.1.3 D-R Burton Healthcare
    • 6.1.4 Medica Holdings, LLC
    • 6.1.5 Monaghan Medical Corporation
    • 6.1.6 PARI GmbH
    • 6.1.7 R. Cegla GmbH & Co. KG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS